Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to levodopa in Parkinson's disease over time. A 4-year follow-up study.
Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, García Díaz I, Íñiguez Alvarado MC, Paz JM, Jesús S, Cosgaya M, García Caldentey J, Caballol N, Legarda I, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Vela L, Escalante S, Mendoza Z, Martínez Castrillo JC, Alonso PS, Alonso Losada MG, López Ariztegui N, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Among authors: vela l. Parkinsonism Relat Disord. 2023 Nov;116:105852. doi: 10.1016/j.parkreldis.2023.105852. Epub 2023 Oct 3. Parkinsonism Relat Disord. 2023. PMID: 37804623
Burden, perceived health status, and mood among caregivers of Parkinson's disease patients.
Martinez-Martin P, Arroyo S, Rojo-Abuin JM, Rodriguez-Blazquez C, Frades B, de Pedro Cuesta J; Longitudinal Parkinson's Disease Patient Study (Estudio longitudinal de pacientes con enfermedad de Parkinson-ELEP) Group. Martinez-Martin P, et al. Mov Disord. 2008 Sep 15;23(12):1673-80. doi: 10.1002/mds.22106. Mov Disord. 2008. PMID: 18709684
Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT).
Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, de Pedro-Cuesta J, Martinez-Martin P; Longitudinal Parkinson's Disease Patient Study, Estudio Longitudinal de Pacients con Enfermedad da Parkinson Group. Rodriguez-Blazquez C, et al. Eur J Neurol. 2010 Feb;17(2):194-201. doi: 10.1111/j.1468-1331.2009.02788.x. Epub 2009 Sep 23. Eur J Neurol. 2010. PMID: 19780808
What contributes to driving ability in Parkinson's disease.
Cubo E, Martinez Martin P, Gonzalez M, Bergareche A, Campos V, Fernández JM, Alvárez M, Bayes A; Elep Group. Cubo E, et al. Disabil Rehabil. 2010;32(5):374-8. doi: 10.3109/09638280903168507. Disabil Rehabil. 2010. PMID: 19958153
Dopaminergic agonists in Parkinson's disease.
Alonso Cánovas A, Luquin Piudo R, García Ruiz-Espiga P, Burguera JA, Campos Arillo V, Castro A, Linazasoro G, López Del Val J, Vela L, Martínez Castrillo JC. Alonso Cánovas A, et al. Among authors: vela l. Neurologia. 2014 May;29(4):230-41. doi: 10.1016/j.nrl.2011.04.012. Epub 2011 Jul 2. Neurologia. 2014. PMID: 21724302 Free article. Review. English, Spanish.
177 results